Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Facchini, Gaetano; Rossetti, Sabrina; Berretta, Massimiliano; Cavaliere, Carla; Scagliarini, Sarah; Vitale, Maria Giuseppa; Ciccarese, Chiara; Di Lorenzo, Giuseppe; Palesandro, Erica; Conteduca, Vincenza; Basso, Umberto; Naglieri, Emanuele; Farnesi, Azzurra; Aieta, Michele; Borsellino, Nicolò; La Torre, Leonardo; Iovane, Gelsomina; Bonomi, Lucia; Gasparro, Donatello; Ricevuto, Enrico; De Tursi, Michele; De Vivo, Rocco; Lo Re, Giovanni; Grillone, Francesco; Marchetti, Paolo; De Vita, Ferdinando; Scavelli, Claudio; Sini, Claudio; Pisconti, Salvatore; Crispo, Anna; Gebbia, Vittorio; Maestri, Antonio; Galli, Luca; De Giorgi, Ugo; Iacovelli, Roberto; Buonerba, Carlo; Cartenì, Giacomo; D’Aniello, Carmine

doi:10.1186/s12967-019-2047-4

Journal of Translational Medicine

Article metrics
Last updated: Sun, 19 May 2024 22:52:54 Z

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Access & Citations

5132

Article Accesses
11

Web of Science
13

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com